LOTTE BIOLOGICS
LIVE

Serial Number

97405521

Owner

LOTTE CORPORATION

Attorney

Michelle Hon Donovan

Filing Date

May 11, 2022

Add to watchlist:

No watchlists yet
View on USPTO

LOTTE BIOLOGICS Trademark

Serial Number: 97405521 • Registration: 7885897

LOTTE BIOLOGICS is a trademark filed by LOTTE CORPORATION on May 11, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

LOTTE CORPORATION (33 trademarks)

300, OLYMPIC-RO, SONGPAG-GU,
SEOUL 05551 , KR

Entity Type: 03

Trademark Details

Filing Date

May 11, 2022

Registration Date

August 12, 2025

Published for Opposition

June 24, 2025

Goods & Services

Custom manufacture of biopharmaceuticals; Processing services in the nature of biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; treatment of biopharmaceutical materials; chemical treatment of liquids; custom manufacture of pharmaceuticals; preservation of pharmaceuticals, namely, cryogenic preservation of pharmaceuticals; processing of medicinal materials, namely, medicinal plants; processing of pharmaceutical preparations, namely, medicinal plants; processing of medical products, namely, medicinal plants; processing of chemicals in the nature of fuel materials; recycling of medical waste; destruction of medical waste; custom manufacture of medical devices for others; custom manufacturing services, namely, custom assembling of electronic components for medical devices; custom manufacturing of dietary supplements for humans; processing and handling of chemical reagents, namely, processing of fuel materials; chemical encapsulation and dispersion of hazardous chemicals; conversion of targeted substrates into targeted chemical preparations by treatment with enzyme systems; processing of blending agents, namely, conversion of targeted substrates into targeted chemical preparations by treatment with enzyme systems; processing of catalysts, namely, conversion of targeted substrates into targeted chemical preparations by treatment with enzyme systems; processing of cell strain for making biopharmaceutical products, namely, conversion of targeted substrates into targeted chemical preparations by treatment with enzyme systems; custom manufacture of cell strain for making biopharmaceutical products; material treatment of cell strain for making biopharmaceutical products

Bouillons for bacteriological cultures; biological reagents for veterinary diagnostic purposes; biological tissue cultures for veterinary purposes; diagnostic test reagents for medical and veterinary purposes; in vitro diagnostic preparations for medical purposes; biological preparations for medical and veterinary purposes, namely, biological preparations for the treatment of cancer; reagents and media for medical and veterinary diagnostic purposes; cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical and veterinary use; cultures of microorganisms for medical use; biological reagents for medical purposes; biological tissue cultures for medical purposes; stem cells for medical purposes; stem cells for medical and veterinary purposes; surgical implants comprising living tissues grown from stem cells; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis and prevention of osteoporosis, cancer; radio-isotope markers for therapeutic or diagnostic use; viral vaccines; reagents for use in diagnostic tests for medical purposes

Enzymes derived from biotechnological processes for use in industry; cell growth media for growing cells for use in scientific research; stem cells for scientific purposes; cells for scientific or laboratory research purposes; preparations for gene recombination, namely, biological preparations for scientific or scientific laboratory purposes; Biological preparations, namely, synthetic genes for scientific research other than for medical purposes; chemicals for use in biotechnological product development; biological preparations for use in biotechnology for use in industry and science, other than medical; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; probiotic bacterial cultures for addition to food products in the food industry; stem cells for research purposes; chemical reagents for use in genetic research, other than for medical or veterinary purpose; chemical reagents for genetic identity testing, other than for medical or veterinary purpose; stem cells other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purpose; reagents for use in scientific apparatus for chemical or biological analysis; biochemicals for in vitro and in vivo scientific use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; preparations of microorganisms, namely, cultures of microorganisms other than for medical and veterinary use

advisory services relating to health; health screening services in the field of asthma, sleep apnea; public health counselling; medical clinics other than dentistry; Medical consultations, namely, consultancy and information services relating to the use of biopharmaceutical products; veterinary services; psychological consultation; Medical consultancy and information services provided via the Internet relating to the use of pharmaceutical products; dispensing of pharmaceuticals; sanatorium services; rental of medical and health care equipment; medical assistance services; Medical information services relating to the use of medical products; dentistry services; Dispensary services, namely, dispensing of Korean medicines; medical treatment services of speech disorders, breast cancer, infertility; medical and managed healthcare services relating to DNA, genetics and genetic testing; provision of health care services in domestic homes; medical treatment of osteoarthritis, cancer using cultured cells; medical services relating to the removal, treatment and processing of stem cells

Massage apparatus; medical apparatus for introducing pharmaceutical preparations into the human body; injection device for pharmaceuticals; inoculating apparatus, namely, needles for medical use; medical apparatus and instruments for use in endovascular, cardiovascular, and endoscopy procedures; medical thread; medical clothing, namely, medical gowns; gloves for medical purposes; automatic vaccination apparatus; orthopedic articles, namely, orthopedic insoles; containers especially adapted for the disposal of syringes; dental equipment, namely, dental excavators; genetic testing apparatus for medical purposes; precision sensors, namely, patient monitoring sensors for medical use; galvanic therapeutic appliances, namely, static electric therapy apparatus; diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, DNA; Cooling pads for first aid purposes; protective masks for medical purposes; medical diagnostic apparatus for testing for viruses; massage apparatus for medical purposes

Microbial culture trials, namely, scientific research in the nature of conducting clinical trials for others; research and development of technology for biotechnology; medical research in the field of crude drugs; bacteriological research and analysis; development of cell therapy products; development of pharmaceutical preparations and medicines; clinical testing of medicines; scientific research in the field of genetic engineering; Scientific genetic research; medical laboratory services; medical research, namely, medicine research; Product development services, namely, analysis and evaluation of medical product development; clinical research in the field of radiology, chemotherapy, coronary artery bypass surgery; stem cell research services; technological services and design relating thereto, namely, technological research in the field of manufacturing processes; research and development of vaccines and medicines; technical consultancy relating to research services in the field of foods and dietary supplements; Product development of devices for biological chemicals analysis; Product design of medical diagnostic apparatus and instruments; providing product information on the testing, inspection, and product research of medical products

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 12, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 12, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 24, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 24, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 18, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 26, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 23, 2025 ERSI
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 19, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 18, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 18, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 18, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 19, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 19, 2024 GNSL
SUSPENSION LETTER WRITTEN
Aug 19, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2024 CRFA
ASSIGNED TO LIE
Aug 17, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 4, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 4, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 4, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 4, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 4, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
May 4, 2023 GNSL
SUSPENSION LETTER WRITTEN
May 4, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 3, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 2, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 2, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 2, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 2, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 2, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 29, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2022 NWOS
NEW APPLICATION ENTERED
May 14, 2022 NWAP